Ian G. Faragher

Impact of the A ustralian National Bowel Cancer Screening Program on Stage at Diagnosis and Stage‐Specific Survival in Colorectal Cancer

Michael Rouse, M. Harold, Vanessa Wong, Margaret Lee et autres

AIM: The Australian National Bowel Cancer Screening Program began in 2006, offering free faecal occult blood testing every 2 years to Australians aged 50-75 years. We hypothesised a difference in overall survival between screen-detected and non-screen-detected colorectal cancer in an Australian cohort, …

au (code pays fourni par la source)

Colorectal cancer survivorship program at a single tertiary centre: has service provision changed after COVID-19?

Rachael Menadue, Lea Tiffany, Shriranshini Satheakeerthy, Aditya Sakalkale et autres

BACKGROUND: Surveillance after colorectal cancer (CRC) resection is an important aspect of survivorship care. This study aimed to assess whether there were any changes to post-operative surveillance uptake in non-metastatic CRC patients and pre- and post-COVID pandemic in Victoria. METHODS: All CRC …

au (code pays fourni par la source)

Factors associated with diagnostic and treatment intervals in colorectal cancer: A linked data study

Allison Drosdowsky, Karen Elaine Lamb, Luc te Marvelde, Peter Gibbs et autres

This research aimed to assess the length of intervals before diagnosis and treatment for colorectal cancer in Australia using linked datasets, and to determine any factors associated with interval length. A colorectal cancer clinical registry was linked to general practice electronic medical …

au (code pays fourni par la source)

“Scoping” sustainability: rethinking sterile water use in colonoscopies

Josua A. Lotter, Kevin‐Ruofan Zhao, MICHAEL W. ROUSE, Ian G. Faragher et autres

au (code pays fourni par la source)

Colorectal cancer survivorship program at a single tertiary centre :– Has service provision changed after Covid-19?

Rachael Menadue, Lea Tiffany, Shriranshini Satheakeerthy, Aditya Sakalkale et autres

au (code pays fourni par la source)

Accuracy of Baseline Magnetic Resonance Imaging for Staging Rectal Cancer Patients Proceeding Directly to Surgery

Elasma Milanzi, Rachel M. Pelly, Ian Hayes, Peter Gibbs et autres

BACKGROUND AND OBJECTIVES: High-resolution magnetic resonance imaging (MRI) accuracy for staging preoperative rectal cancer varies across studies. We examined MRI accuracy for T- and N-staging of rectal cancer compared with final histopathology of the resected specimen in a large Australian cohort who …

au (code pays fourni par la source)

It's time to consider screening for anal cancer in high risk populations

Matthew Yuan-Kun Wei, Justin M Yeung, Ian G. Faragher

Community groups and medical bodies such as the US Center for Disease Control have called for establishment of screening programs for anal cancer in high-risk groups.1 Over 90% of anal squamous cell carcinoma (aSCC) is caused by human papilloma virus (HPV) infection, …

au (code pays fourni par la source)

Body composition assessment by artificial intelligence can be a predictive tool for short-term postoperative complications in Hartmann’s reversals

Reshi Suthakaran, Ke Cao, Yasser Arafat, Josephine Yeung et autres

Abstract Background Hartmann's reversal, a complex elective surgery, reverses and closes the colostomy in individuals who previously underwent a Hartmann's procedure due to colonic pathology like cancer or diverticulitis. It demands careful planning and patient optimisation to help reduce postoperative complications. Preoperative …

au (code pays fourni par la source)

Artificial intelligence measured 3D body composition to predict pathological response in rectal cancer patients

Matthew Yuan-Kun Wei, Ke Cao, Wei Hong, Josephine Yeung et autres

BACKGROUND: The treatment of locally advanced rectal cancer (LARC) is moving towards total neoadjuvant therapy and potential organ preservation. Of particular interest are predictors of pathological complete response (pCR) that can guide personalized treatment. There are currently no clinical biomarkers which can …

au (code pays fourni par la source)

Colorectal cancer treatment outcomes during the pandemic: Our experience of COVID‐19 at a tertiary referral center

Christy Kei, Richard Gartrell, Yasser Arafat, Elizabeth Degabriele et autres

BACKGROUNDS: The coronavirus disease 2019 (COVID-19) has led to major shifts in the management of colorectal cancer (CRC). This study aims to identify the impact and early outcomes of COVID-19 following CRC management at a tertiary referral center in Victoria, Australia. METHODS: …

au (code pays fourni par la source)

Body composition assessment by Artificial Intelligence can be a predictive tool for short-term postoperative complications in Hartmann’s reversals

Reshi Suthakaran, Ke Cao, Yasser Arafat, Josephine Yeung et autres

Abstract Background Hartmann’s reversal is a complex elective procedure that requires careful planning and patient optimisation to help reduce postoperative complications. Preoperative evaluation of body composition has been useful in identifying patients at high risk of short-term postoperative outcomes following colorectal cancer …

au (code pays fourni par la source)

Can sarcopenia predict survival in locally advanced rectal cancer patients?

Richard Gartrell, Jing Qiao, Nicole K. Kiss, Ian G. Faragher et autres

BACKGROUND: There is mounting evidence that suggests sarcopenia can be used to predict survival outcomes in patients with colon cancer. However, the effect on locally advanced rectal cancer (LARC) is less clear. We sought to determine the association between sarcopenia on Overall …

au (code pays fourni par la source)